Dexamethasone-eluting stents had sustained favorable ischemic driven target lesion revascularization rates over 5 years: A randomized controlled prospective study

International Journal of Cardiology

Volumn 165, Issue 2, 2013, Pages 359-362

  Park, Yae Min ^a   Han, Seung Hwan ^a   Lee, Kyounghoon ^a   Suh, Soon Yong ^a   Oh, Pyung Chun ^a   Chung, Wook Jin ^a   Kang, Woong Chol ^a   Koh, Kwang Kon ^a   Ahn, Tae Hoon ^a   Choi, In Suk ^a   Shin, Eak Kyun ^a  

^a Gachon University College of Medicine   (South Korea)

Author keywords

coronary stent; dexamethasone; major adverse cardiac event

Indexed keywords

DEXAMETHASONE; PHOSPHORYLCHOLINE;

ACUTE CORONARY SYNDROME; ADULT; ANGIOCARDIOGRAPHY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DEXAMETHASONE ELUTING STENT; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; IN-STENT RESTENOSIS; LETTER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; REVASCULARIZATION; SILENT MYOCARDIAL ISCHEMIA; STABLE ANGINA PECTORIS; THORAX PAIN; BARE METAL STENT; BILIARY SEPSIS; CACHEXIA; DRUG ELUTING CORONARY STENT; HEART DISEASE; LUNG CANCER; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; PHOSPHORYLCHOLINE COATED STENT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEPSIS; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; TARGET LESION REVASCULARIZATION; UNSTABLE ANGINA PECTORIS;

EID: 84876669533     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2012.08.033     Document Type: Article

References (24)

1. A. Farb, D.K. Weber, F.D. Kolodgie, A.P. Burke, and R. Virmani Morphological predictors of restenosis after coronary stenting in humans Circulation 105 2002 2974 2980
2. P.R. Moreno, V.H. Bernardi, and J. Lopez-Cuellar Macrophage infiltration predicts restenosis after coronary intervention in patients with unstable angina Circulation 94 1996 3098 3102
3. R.G. Macdonald, R.S. Panush, and C.J. Pepine Rationale for use of glucocorticoids in modification of restenosis after percutaneous transluminal coronary angioplasty Am J Cardiol 60 1987 56B 60B
4. X. Liu, I. De Scheerder, and W. Desmet Dexamethasone-eluting stent: an anti-inflammatory approach to inhibit coronary restenosis Expert Rev Cardiovasc Ther 2 2004 653 660
5. F. Ribichini, F. Tomai, and V. Ferrero Immunosuppressive oral prednisone after percutaneous interventions in patients with multi-vessel coronary artery disease. The IMPRESS-2/MVD study EuroIntervention 1 2005 173 180
6. V. Ferrero, F. Tomai, and F. Versaci Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levels EuroIntervention 5 2009 250 254
7. F. Versaci, A. Gaspardone, and F. Tomai et al.; Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation Study. Immunosuppressive Therapy for the Prevention of Restenosis after Coronary Artery Stent Implantation (IMPRESS Study) J Am Coll Cardiol 40 2002 1935 1942
8. S.H. Han, T.H. Ahn, and W.C. Kang The favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: randomized controlled prospective study Am Heart J 152 887 2006 e1 e7
9. X. Liu, Y. Huang, and C. Hanet Study of antirestenosis with the BiodivYsio dexamethasone-eluting stent (STRIDE): a first-in-human multicenter pilot trial Catheter Cardiovasc Interv 60 2003 172 178
10. R. Hoffmann, P.W. Radke, and J.R. Ortlepp Intravascular ultrasonic comparative analysis of degree of intimal hyperplasia produced by four different stents in the coronary arteries Am J Cardiol 94 2004 1548 1550
11. G. Patti, V. Pasceri, and P. Carminati Effect of dexamethasone-eluting stents on systemic inflammatory response in patients with unstable angina pectoris or recent myocardial infarction undergoing percutaneous coronary intervention Am J Cardiol 95 2005 502 505
12. A. Konig, M. Leibig, and J. Rieber Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: serial angiographic and sonographic analysis Am Heart J 153 979 2007 e1 8
13. G. Pesarini, V. Ferrero, and F. Tomai Dexamethasone-Eluting Stent Italian Registry Investigators. Steroid-eluting stents in patients with acute coronary syndromes. Angiographic results of DESIRE: Dexamethasone-Eluting Stent Italian Registry J Invasive Cardiol 21 2009 86 91
14. F. Ribichini, F. Tomai, and L. Paloscia DESIRE investigators. Steroid-eluting stents in patients with acute coronary syndrome: the Dexamethasone Eluting Stent Italian Registry Heart 93 2007 598 600
15. S. Jimenez-Valero, B. Santos, and F. Pajin Clinical outcomes of dexametasone-eluting stent implantation in ST-elevation acute myocardial infarction Catheter Cardiovasc Interv 70 2007 492 497
16. N. Ozer, B. Tangurek, and F. Firat Effects of drug-eluting stents on systemic inflammatory response in patients with unstable angina pectoris undergoing percutaneous coronary intervention Heart Vessels 23 2008 75 82
17. J. Fajadet, W. Wijns, and G.J. Laarman Long-term follow-up of the randomised controlled trial to evaluate the safety and efficacy of the zotarolimus-eluting driver coronary stent in de novo native coronary artery lesions: five year outcomes in the ENDEAVOR II study EuroIntervention 6 2010 562 567
18. M. Wiemer, P.W. Serruys, and K. Miquel-Hebert Five-year long-term clinical follow-up of the XIENCE V Everolimus eluting coronary stent system in the treatment of patients with de novo coronary artery lesions: the SPIRIT FIRST trial Catheter Cardiovasc Interv 75 2010 997 1003
19. J.W. Kim, H.S. Seo, and J.Y. Park A prospective, randomized, 6-month comparison of the coronary vasomotor response associated with a zotarolimus-versus a sirolimus-eluting stent: differential recovery of coronary endothelial dysfunction J Am Coll Cardiol 53 2009 1653 1659
20. A. Jeremias, B. Sylvia, and J. Bridges Stent thrombosis after successful sirolimus-eluting stent implantation Circulation 109 2004 1930 1932
21. E.P. McFadden, E. Stabile, and E. Regar Late thrombosis in drug-eluting coronary stents after discontinuation of antiplatelet therapy Lancet 364 2004 1519 1521
22. G. Nakazawa, A.V. Finn, and M. Vorpahl Coronary responses and differential mechanisms of late stent thrombosis attributed to first-generation sirolimus-and paclitaxel-eluting stent J Am Coll Cardiol 57 2011 390 398
23. Q.K. Guo, Z.Q. Lu, J.Y. Wang, and T. Li In vivo evaluation of a novel dexamethasone-heparin-double-coated stent for inhibition of artery restenosis and thrombosis J Mater Sci Mater Med 22 2011 1615 1623
24. L. Lei, S.R. Guo, W.L. Chen, H.J. Rong, and F. Lu Stents as a platform for drug delivery Expert Opin Drug Deliv 8 2011 813 831